emtricitabine/rilpivirine/tenofovir alafenamide

emtricitabine/rilpivirine/tenofovir alafenamide is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

General

Pronunciation:
em-tri-sye-ti-been/ril-pi-vir-een/te-noe-fo-veer al-a-fen-a-mide

Trade Name(s)

  • Odefsey

Ther. Class.
antiretrovirals

Pharm. Class.
nucleoside reverse transcriptase inhibitors
non nucleoside reverse transcriptase inhibitors

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - emtricitabine/rilpivirine/tenofovir alafenamide ID - 110455 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110455/all/emtricitabine_rilpivirine_tenofovir_alafenamide PB - F.A. Davis Company ET - 16 DB - Pediatrics Central DP - Unbound Medicine ER -